Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hongwei Ling
Institutions:
Xuzhou Medical College,
Affiliated Hospital of Xuzhou Medical College
Observed institutions:
Xuzhou Medical College,
Affiliated Hospital of Xuzhou Medical College
ORCID:
0009-0007-5702-4969
Observed ORCID:
0009-0007-5702-4969
OpenAlex ID:
A5050872625
Efficacy and safety of cAMP-biased GLP-1 receptor agonist ecnoglutide versus dulaglutide in patients with type 2 diabetes and elevated glucose concentrations on metformin monotherapy (EECOH-2): a 52-week, multicentre, open-label, non-inferiority, randomised, phase 3 trial
2025
·
Yang He
, Nianrong Mi
, et al.
·
The Lancet Diabetes & Endocrinology
·
15
Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trial
2025
·
Dalong Zhu
, Jianhua Ma
, et al.
·
Diabetologia
·
8
Efsubaglutide alfa added to metformin improves glycaemia with β-cell functional responses in type 2 diabetes: a randomised, double-blind, placebo-controlled, two-stage adaptive phase 2b/3 trial (SUPER 2)
2026
·
Weiping Jia
, Fei Gao
, et al.
·
Nature Communications
·
2
PDF
Performance of the Fifth Generation of a 16-Day Continuous Glucose Monitoring System in Adults with Diabetes
2026
·
Shichen Chang
, Yibing Lu
, et al.
·
Diabetes Technology & Therapeutics
·
2
Efficacy and safety of insulin degludec biosimilar B01411 versus originator insulin degludec in Chinese patients with type 2 diabetes inadequately controlled on oral antidiabetic drugs: a multicenter, randomized, open-label, phase 3 study
2024
·
Linong Ji
, Leili Gao
, et al.
·
Current Medical Research and Opinion
·
1
Development of a risk identification model for sPTB in patients with GDM based on ensemble learning algorithms
2026
·
Jie Hao
, Ying Rong
, et al.
·
BMC Pregnancy and Childbirth
A Prospective Multicenter Assessment of the Accuracy and Safety of the Yuwell CT3 Real‐Time Continuous Glucose Monitoring System in Patients With Diabetes Over 14 Days
2026
·
Lingli Zhou
, Yufeng Li
, et al.
·
Journal of Diabetes
Performance and Safety of a 15-Day Real-Time Continuous Glucose Monitoring System in Chinese Adults With Diabetes: A Multicenter Trial
2026
·
Mei Zhang
, Yibing Lu
, et al.
·
Journal of Diabetes Science and Technology
Correction: Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trial
2026
·
Dalong Zhu
, Jianhua Ma
, et al.
·
Diabetologia
PDF
Exenatide through PPARδ improved hepatic insulin resistance in patients of type 2 diabetes mellitus via suppressing pyroptosis
2026
·
Xizhi Li
, Tingting Zhou
, et al.
·
International Immunopharmacology
Show more works
View as search
Works count:
10
Citation count:
28
H-index:
2
I10-index:
1
Year
Topic
Type